Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.03 +0.02 (+1.98%)
As of: Oct 21, 2026 · 3:42 PM EDT

Telomir Pharmaceuticals (TELO) Non-Current Debt (2023 - 2024)

Updated

Telomir Pharmaceuticals (TELO) posted Non-Current Debt of $1.00 for Q4 2024, down 100.0% from $951,881 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Non-Current Debt (2023 - 2024) Analysis & Trends

For FY2024, Telomir Pharmaceuticals' Non-Current Debt came in at -$433,945.

  • In prior years, Telomir Pharmaceuticals' Non-Current Debt was $1.66 million in FY2023 (+259.7%) and $462,391 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 62.48 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 60.50 Bn
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.00
Sep 30, 2024 85,529.00
Mar 31, 2024 -519,475.00
Dec 31, 2023 951,881.00
Jun 30, 2023 -317,389.00
Mar 31, 2023 -263,873.00
API Access

Telomir Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TELO&period=max&api_key=YOUR_API_KEY